To get profit without risk, experience without danger, and reward without work, is as impossible as it is to live without being born.

It is possible that pharmaceutical group stock momentum could carry (Lilly) higher, but we believe the risk/reward warrants a neutral rating.

It's too much risk for too little reward.

Non-profit work has been a great experience for me for over 30 years and I will miss the notion of training young people to manage our future,

If risk aversion goes up there could be profit-taking in the equity markets and that is a major risk.

With payrolls so close, people are looking at risk/reward and deciding to be safe.